140 related articles for article (PubMed ID: 7929408)
1. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
Newton DL; Nicholls PJ; Rybak SM; Youle RJ
J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
[TBL] [Abstract][Full Text] [Related]
2. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
[TBL] [Abstract][Full Text] [Related]
3. Expression in Escherichia coli and purification of human eosinophil-derived neurotoxin with ribonuclease activity.
Sun L; Li MS; Fisher LM; Spry CJ
Protein Expr Purif; 1995 Oct; 6(5):685-92. PubMed ID: 8535163
[TBL] [Abstract][Full Text] [Related]
4. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
5. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.
Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM
Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of recombinant rat eosinophil-associated ribonucleases, homologues of human eosinophil cationic protein and eosinophil-derived neurotoxin, and their characterization.
Nakajima M; Hirakata M; Nittoh T; Ishihara K; Ohuchi K
Int Arch Allergy Immunol; 2001 Jul; 125(3):241-9. PubMed ID: 11490157
[TBL] [Abstract][Full Text] [Related]
8. Characterization of single-chain antibody (sFv)-toxin fusion proteins produced in vitro in rabbit reticulocyte lysate.
Nicholls PJ; Johnson VG; Andrew SM; Hoogenboom HR; Raus JC; Youle RJ
J Biol Chem; 1993 Mar; 268(7):5302-8. PubMed ID: 8444903
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family.
Rosenberg HF; Tenen DG; Ackerman SJ
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4460-4. PubMed ID: 2734298
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
Goyal A; Batra JK
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil cationic protein and eosinophil-derived neurotoxin. Evolution of novel function in a primate ribonuclease gene family.
Rosenberg HF; Dyer KD
J Biol Chem; 1995 Sep; 270(37):21539-44. PubMed ID: 7665566
[TBL] [Abstract][Full Text] [Related]
13. Humanization of immunotoxins.
Rybak SM; Hoogenboom HR; Meade HM; Raus JC; Schwartz D; Youle RJ
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3165-9. PubMed ID: 1565609
[TBL] [Abstract][Full Text] [Related]
14. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine.
Reimert CM; Minuva U; Kharazmi A; Bendtzen K
J Immunol Methods; 1991 Jul; 141(1):97-104. PubMed ID: 1865126
[TBL] [Abstract][Full Text] [Related]
16. Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity.
Rosenberg HF; Dyer KD
Nucleic Acids Res; 1997 Sep; 25(17):3532-6. PubMed ID: 9254715
[TBL] [Abstract][Full Text] [Related]
17. Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.
Ye Q; Hu H; Wang Z; Lu T; Hu Z; Zeng X; Zhang S; Liu J; Lei P; Wang CY; Ye Z; Shen G
BMC Biotechnol; 2012 Nov; 12():91. PubMed ID: 23192001
[TBL] [Abstract][Full Text] [Related]
18. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.
Suzuki M; Saxena SK; Boix E; Prill RJ; Vasandani VM; Ladner JE; Sung C; Youle RJ
Nat Biotechnol; 1999 Mar; 17(3):265-70. PubMed ID: 10096294
[TBL] [Abstract][Full Text] [Related]
19. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
[TBL] [Abstract][Full Text] [Related]
20. X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 A resolution.
Mosimann SC; Newton DL; Youle RJ; James MN
J Mol Biol; 1996 Jul; 260(4):540-52. PubMed ID: 8759319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
